Rezolute Inc. (NASDAQ: RZLT) met with the U.S. Food and Drug Administration on March 17 to discuss its sunRIZE Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE